Department of Legal Medicine, Osaka City University Medical School, Asahi-machi 1-4-3, Abeno, 545-8585 Osaka, Japan.
Forensic Sci Int. 2010 Dec 15;203(1-3):83-92. doi: 10.1016/j.forsciint.2010.07.024. Epub 2010 Aug 16.
In forensic pathology, while classical morphology remains a core procedure to investigate deaths, a spectrum of ancillary procedures has been developed and incorporated to detail the pathology. Among them, postmortem biochemistry is important to investigate the systemic pathophysiological changes involved in the dying process that cannot be detected by morphology. In addition, recent advances in molecular biology have provided a procedure to investigate genetic bases of diseases that might present with sudden death, which is called 'molecular autopsy'. Meanwhile, the practical application of RNA analyses to postmortem investigation has not been accepted due to rapid decay after death; however, recent experimental and practical studies using real-time reverse transcription-PCR have suggested that the relative quantification of mRNA transcripts can be applied in molecular pathology for postmortem investigation of deaths, which may be called 'advanced molecular autopsy'. In a broad sense, forensic molecular pathology implies applied medical sciences to investigate the genetic basis of diseases, and the pathophysiology of diseases and traumas leading to death at a biological molecular level in the context of forensic pathology. The possible applications include analyses of local pathology, including tissue injury, ischemia/hypoxia and inflammation at the site of insult or specific tissue damage from intoxication, systemic responses to violence or environmental hazards, disorders due to intoxication, and systemic pathophysiology of fatal process involving major life-support organs. A review of previous studies suggests that systematic postmortem quantitative analysis of mRNA transcripts can be established from multi-faceted aspects of molecular biology and incorporated into death investigations in forensic pathology, to support and reinforce morphological evidence.
在法医病理学中,虽然经典形态学仍然是研究死亡的核心程序,但已经开发并纳入了一系列辅助程序来详细研究病理学。其中,死后生物化学对于研究无法通过形态学检测到的死亡过程中的系统病理生理变化非常重要。此外,分子生物学的最新进展提供了一种调查可能导致猝死的疾病遗传基础的程序,称为“分子尸检”。同时,由于死后迅速衰减,RNA 分析在死后调查中的实际应用尚未被接受;然而,最近使用实时逆转录-PCR 的实验和实际研究表明,mRNA 转录物的相对定量可以应用于分子病理学,用于死后死亡调查,这可能被称为“高级分子尸检”。从广义上讲,法医分子病理学意味着应用医学科学在法医病理学背景下从生物分子水平研究疾病的遗传基础、疾病和创伤的病理生理学以及导致死亡的因素。可能的应用包括局部病理学分析,包括损伤、缺血/缺氧和炎症部位的组织损伤,或中毒引起的特定组织损伤、暴力或环境危害引起的全身反应、中毒引起的疾病以及涉及主要生命支持器官的致命过程的全身病理生理学。对以往研究的回顾表明,可以从分子生物学的多个方面建立系统性死后定量分析 mRNA 转录物,并将其纳入法医病理学中的死亡调查,以支持和加强形态学证据。